65
Participants
Start Date
March 31, 2008
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
AZD1305
AZD1305 loading dose 250 mg + 125 mg evening dose on Study Day 1, maintenance dose 125 mg twice daily from Study Day 2
AZD1305
AZD1305 loading dose 500 mg + placebo evening dose on Study Day 1, maintenance dose 125 mg twice daily from Study Day 2
Placebo
Placebo corresponding to AZD1305 loading dose + evening dose on Study Day 1, maintenance dose twice daily from Study Day 2
Research Site, Aalborg
Research Site, Copenhagen
Research Site, Esbjerg
Research Site, Hvidovre
Research Site, Silkeborg
Research Site, Svendborg
Research Site, Oslo
Research Site, Rud
Research Site, Tynset
Research Site, Bytom
Research Site, Warsaw
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Košice
Research Site, Nitra
Research Site, Nové Zámky
Research Site, Rimavská Sobota
Research Site, Gothenburg
Lead Sponsor
AstraZeneca
INDUSTRY